Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0093 | 0.776 | 0.5 |
Schistosoma mansoni | kinase | 0.0047 | 0.3584 | 0.4619 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0093 | 0.776 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.3397 | 0.4378 |
Echinococcus multilocularis | tar DNA binding protein | 0.0065 | 0.5172 | 0.6665 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.3397 | 0.4378 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.3397 | 0.4378 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0093 | 0.776 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.0093 | 0.776 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0093 | 0.776 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.3397 | 0.3397 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0117 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0065 | 0.5172 | 0.5172 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0093 | 0.776 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0065 | 0.5172 | 0.6665 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.5172 | 0.6665 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.3397 | 0.4378 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0093 | 0.776 | 0.776 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.3397 | 0.4378 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.776 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0093 | 0.776 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.3397 | 0.4378 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.5172 | 0.6665 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.5172 | 0.6665 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0093 | 0.776 | 0.5 |
Brugia malayi | RNA binding protein | 0.0065 | 0.5172 | 0.5172 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.776 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.5172 | 0.6665 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0093 | 0.776 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0065 | 0.5172 | 0.5172 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.3397 | 0.4378 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0065 | 0.5172 | 0.5172 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.776 | 1 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0093 | 0.776 | 0.776 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.776 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.3397 | 0.3397 |
Loa Loa (eye worm) | RNA binding protein | 0.0065 | 0.5172 | 0.5172 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0065 | 0.5172 | 0.5172 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.5172 | 0.6665 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.776 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.776 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.776 | 1 |
Giardia lamblia | Kinase, PLK | 0.0093 | 0.776 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0117 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.